Companies

Sable Bio

sablebio.com

AI-powered platform for navigating drug target toxicology and predicting safety risks in drug discovery.

Employees11-50
Funding$5.75M
Valuation$15M - $22M
Revenue$0.5M
3 active roles
Healthcare AIAI ApplicationB2B SaaSSeed$1M-$10M

About

Sable Bio provides an AI-powered platform for drug target safety intelligence, helping pharmaceutical and biotech companies predict toxicity risks early in the development process. The platform leverages LLMs and causal inference to analyze multimodal biomedical data from clinical, genetic, and literature sources. The company generates revenue through B2B subscriptions and licenses for its predictive safety tools.

Active Roles

3

Key Investors

MMC Ventures, Episode 1 Ventures, Seedcamp